| | % | % 5 Tage | % 1. Jan. | Veränd. 1 J. | Veränd. 3 J. | Wert (M$) |
 | REGENERON PHARMACEUTICALS, INC. | 2.22% | 9.68% | 13.65% | 20.58% | 90.80% | 87 515 |
| | | | | | | |
| VERTEX PHARMACEUTICALS | 3.16% | 6.30% | 8.87% | 23.80% | 49.65% | 80 827 |
 | WUXI APPTEC CO., LTD. | -0.17% | 8.30% | -1.06% | -27.05% | 39.33% | 34 805 |
| BIONTECH SE | -0.92% | -1.11% | -14.66% | -20.42% | 171.61% | 31 155 |
 | GENMAB A/S | 1.10% | 2.55% | -12.34% | 8.78% | 102.51% | 24 291 |
| BEIGENE, LTD. | 0.32% | -1.62% | -0.10% | 14.06% | 80.33% | 22 935 |
 | ARGENX SE | 0.54% | -1.03% | -3.90% | 22.20% | 180.08% | 20 008 |
| SAREPTA THERAPEUTICS, INC. | 1.41% | 6.11% | 0.47% | 68.49% | 37.72% | 11 454 |
| NEUROCRINE BIOSCIENCES, INC. | 1.42% | 2.97% | -18.75% | 3.55% | 7.56% | 9 374 |
| LEGEND BIOTECH CORPORATION | 5.11% | 0.74% | -7.73% | 24.89% | --.--% | 7 711 |
| KARUNA THERAPEUTICS, INC. | 3.52% | -4.81% | -7.17% | 51.84% | 172.27% | 6 818 |
| EXELIXIS, INC. | 0.82% | 5.30% | 15.21% | -15.54% | 17.18% | 5 989 |
| ASCENDIS PHARMA A/S | -0.56% | -3.00% | -14.11% | -8.30% | -5.45% | 5 896 |
| HALOZYME THERAPEUTICS, INC. | 2.40% | 4.26% | -39.38% | -9.43% | 103.48% | 4 670 |
| INTRA-CELLULAR THERAPIES, INC. | 1.83% | 1.61% | -11.70% | -23.12% | 209.27% | 4 452 |
 | PHARMAESSENTIA CORPORATION | 1.27% | -2.55% | -7.86% | 37.56% | 579.29% | 4 371 |
| | | | | | | |
| | Durchschnitt | 1.42% | 1.60% | -7.61% | 10.09% | 124.63% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | 1.40% | 3.16% | -2.54% | 9.33% | 91.22% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
